WEP Clinical is committed to supporting companies in the pharmaceutical industry to help make much-needed medicines available to patients, physicians, hospitals and research and development centers around the world. The case studies below help demonstrate our capabilities and expertise and highlight the best-in-class service we provide.

Using expanded access to treat patients that do not qualify for the clinical trial

CLICK HERE

USING EXPANDED ACCESS TO PROVIDE CONTINUATION OF TREATMENT POST CLINICAL TRIALS

CLICK HERE

USING EXPANDED ACCESS AS AN ALTERNATIVE TO AN OPEN LABEL EXTENSION (OLEX) STUDY

CLICK HERE

USING EXPANDED ACCESS To supply a large global patient population

CLICK HERE

USING EXPANDED ACCESS TO TREAT VARIOUS PATIENT GROUPS

CLICK HERE

navigating fda approval while providing treatment access through an EXPANDED ACCESS program

CLICK HERE

NAVIGATING THROUGH sponsor aquisitions and changeovers while providing an EXPANDED ACCESS program

CLICK HERE

adjusting to new brexit landscape while providing an EXPANDED ACCESS program

CLICK HERE

NEED MORE INFORMATION?

CONTACT US